Global Metabolomics Market

Global Metabolomics Market Size, Share, Growth Analysis, By Product and service(Metabolomics Instruments, Separation Tools), By End-use(Academic and Research Institutes, Pharmaceutical & Biotechnology Companies) - Industry Forecast 2024-2031

Report ID: SQMIG35H2164 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 64 | Figures: 75

Global Metabolomics Market News

  • The Metabolomics in Life Science conference, held in Umeå, Sweden in February 2024, presented state-of-the-artwork in NMR- and MS-based metabolomics. Global scientists gathered to share information, investigate applications, and promote cooperation. The occasion highlighted the collaborations between Umeå University's Computational Analytics Support Platform (CASP) and SciLifeLab departments.

  • To carry out in-depth metabolomics research, MetaSight Diagnostics and the KSM Research and Innovation Center partnered in July 2023.

  • Waters released changes to its SELECT SERIESTM MRT System in June 2023. These updates increase the system's selectivity and usefulness for mass spectrometry imaging investigations, drug discovery, and UPLC-MS/MS metabolomics applications.

  • CosmosID introduced its metabolomics services in January 2023 with the intention of assisting multi-omics microbiome research.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Metabolomics Market size was valued at USD 2.83 Billion in 2022 and is poised to grow from USD 3.20 Billion in 2023 to USD 8.50 Billion by 2031, at a CAGR of 13 % during the forecast period (2024-2031).

The global metabolomics market is highly competitive and consists of several key players vying for market share. These companies focus on strategic initiatives such as mergers and acquisitions, collaborations, product launches, and partnerships to strengthen their market position. Here is an elaboration on the competitive landscape of the global metabolomics market. These are just a few examples of the key players in the global metabolomics market. The competitive landscape is dynamic, with ongoing developments in technology and research driving competition among market players. Continuous innovation, product expansion, and strategic collaborations are key strategies employed by these companies to maintain a competitive edge in the market. 'Agilent Technologies, Inc. (US)', 'Thermo Fisher Scientific, Inc. (US)', 'Shimadzu Corporation (Japan)', 'Waters Corporation (US)', 'Bruker Corporation (US)', 'PerkinElmer, Inc. (US)', 'Danaher Corporation (US)', 'Bio-Rad Laboratories, Inc. (US)', 'Metabolon, Inc. (US)', 'Human Metabolome Technologies, Inc. (Japan)', 'Agios Pharmaceuticals, Inc. (US)', 'LECO Corporation (US)', 'Biocrates Life Sciences AG (Austria)', 'Shimazu Europe GmbH (Germany)', 'Eurofins Scientific (Luxembourg)', 'Molecular Devices, LLC (US)', 'Phenomenex, Inc. (US)', 'Cambridge Isotope Laboratories, Inc. (US)', 'Sciex (US)', 'JEOL Ltd. (Japan)'

The continuous advancements in metabolomics technologies, such as mass spectrometry, NMR spectroscopy, and data analysis tools, have been a major driver of the market. These advancements enhance the sensitivity, accuracy, and throughput of metabolomics analysis, enabling researchers to generate more meaningful insights from metabolomics data.

Integration of Multi-Omics Approaches: the integration of multi-omics approaches, combining metabolomics data with genomics, proteomics, and transcriptomics data. This integration allows for a comprehensive understanding of biological systems and provides insights into complex biological processes and disease mechanisms. The integration of multi-omics data is expected to drive advancements in systems biology and personalized medicine.

North America is the dominating region in the global metabolomics market. The region has a strong presence of major pharmaceutical and biotechnology companies, academic and research institutes, and advanced healthcare infrastructure, which contribute to the market's dominance. The region has witnessed significant investments in metabolomics research and development, along with government initiatives to promote precision medicine and personalized healthcare. The availability of skilled professionals, technological advancements, and supportive regulatory frameworks further contribute to the dominance of North America in the metabolomics market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global Metabolomics Market

Report ID: UCMIG35H2223 | Region: Global | Published Date: March, 2024 | Pages: 165 | Tables: Figures:

Type 1 Diabetes Market
Buy Now GET FREE SAMPLE
Global Metabolomics Market

Report ID: UCMIG35H2139 | Region: Global | Published Date: March, 2024 | Pages: 165 | Tables: Figures:

DNA Methylation Market
Buy Now GET FREE SAMPLE
Global Metabolomics Market

Report ID: UCMIG35H2214 | Region: Global | Published Date: March, 2024 | Pages: 165 | Tables: Figures:

Organoids And Spheroids Market
Buy Now GET FREE SAMPLE
Global Metabolomics Market

Report ID: UCMIG35H2048 | Region: Global | Published Date: March, 2024 | Pages: 165 | Tables: Figures:

Precision Oncology Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Metabolomics Market

Product ID: SQMIG35H2164

$5,300
BUY NOW GET FREE SAMPLE